Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Renub Research | PRODUCT CODE: 1725910

Cover Image

PUBLISHER: Renub Research | PRODUCT CODE: 1725910

Europe Hip Replacement Market Size and Growth Trends and Forecast Report 2025-2033

PUBLISHED:
PAGES: 200 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2990
PDF (5 User License + Excel)
USD 3490
PDF (Corporate License)
USD 3990

Add to Cart

Europe Hip Replacement Market Trends & Summary

Europe Hip Replacement Market is expected to reach US$ 2.78 billion by 2033 from US$ 1.95 billion in 2024, with a CAGR of 4.04% from 2025 to 2033. An ageing population, the increase in hip disorders, advances in surgical methods, increasing costs of healthcare, requirements for minimally invasive procedures, and improved awareness of joint well-being and quality of life are driving the European hip replacement market.

Europe Hip Replacement Market Report by Product (Total HIP Replacement, Partial HIP Replacement, and Revision HIP Replacement), End-User (Hospitals & Surgery Centers, Orthopaedic clinics, and Others), Countries and Company Analysis 2025-2033.

Europe Hip Replacement Industry Overview

Hip replacement surgery, also known as hip arthroplasty, is the process of replacing a damaged or injured hip joint with an artificial joint, or prosthesis. Individuals suffering from severe disorders of the hip joint, including osteoarthritis, rheumatoid arthritis, avascular necrosis, hip fractures, or other injuries or conditions affecting the hip, usually have the operation to alleviate pain and enhance mobility. Hip replacement surgery is usually performed under general anesthesia, and the doctor may use minimally invasive surgery or open surgery.

The growing population with increasing incidence of age-related disorders of the hip such as osteoarthritis is one of the factors contributing to the push in the European hip replacement market. Hip replacements are increasingly required due to physically inactive lifestyles and increasing obesity rates. Advances in medical technology in the form of robotic-assisted procedures and minimal invasive procedures have made procedures increasingly attractive by providing better outcomes and reducing recuperation periods. Additionally, increasing healthcare expenditures, friendly reimbursement policies, and increased awareness regarding joint health all drive the market growth. In addition, demand for hip replacement solutions is fueled by the increasing demand for high-performance, customized implants.

Growth Drivers for the Europe Hip Replacement Market

Technological Advancements

The European hip replacement market is undergoing significant growth with the aid of technological advancements. Technological advances such as robotic-assisted surgeries and minimally invasive surgery techniques enhance patient outcomes, accelerate recovery, and enhance surgical accuracy. The August 2023 announcement by Nuffield Health Warwickshire Hospital to introduce the Mako robot-assisted surgery system for hip replacements is a notable example. As compared to traditional methods, this advanced technology allows surgeons to perform incredibly accurate and personalized procedures that yield better alignment and faster recovery. In addition, advances in implant materials, such as ceramic and titanium parts, enhance longevity and reduce issues. These technological advancements are making hip replacements more widely available and attractive, which is driving market growth across Europe.

Increasing Prevalence of Hip Disorders

Among the most significant drivers of the growth of the European hip replacement market is the increasing prevalence of hip diseases. A substantial proportion of the elderly in Europe experience hip osteoarthritis (HOA), the leading cause of hip pain and dysfunction. Incidence of hip diseases grows with age, especially over the age of fifty, and lifestyle factors such as obesity and inactivity exacerbate this pattern. Since patients seek effective methods of alleviating their pain and enhancing their mobility, the occurrence of these disorders increases, thereby boosting the demand for hip replacement surgeries. This trend is expected to persist, which will fuel the growth of the market.

Rising Awareness and Healthcare Spending

The European market for hip replacement is primarily fueled by increased awareness and increasing healthcare expenditure. Increasing awareness of joint health as the population grows older has seen more individuals look for surgical intervention. Meanwhile, healthcare expenditure has risen across Europe, enhancing the quality and access to healthcare services. The market is expanding due to rising use of hip replacement surgeries facilitated by improved healthcare financing and informed individuals. In addition, advances in implant technology and surgical methods have enhanced patient results and confidence, leading to growing demand for hip replacements in the region.

Challenges in the Hip Replacement Market

High Costs

The market for hip replacements is severely hampered by high prices. Many patients may find the costs of the procedure, including as implants, hospital stays, and rehabilitation, to be prohibitive, particularly in nations with underfunded healthcare systems or insufficient insurance coverage. Out-of-pocket costs may discourage those without enough insurance from having the operation, which would restrict their access to essential treatments. Furthermore, specialist implants and pricey technologies add to the growing expense of hip replacement procedures.

Post-Surgery Rehabilitation

One of the biggest obstacles in the hip replacement business is post-surgery rehabilitation. Comprehensive physical treatment is necessary for a successful recovery, but it can be expensive and time-consuming. Recovery outcomes are impacted by regional differences in access to high-quality rehabilitation programs, especially in rural areas. Additionally, patients may have trouble following rehabilitation guidelines, which could result in problems or longer recovery durations. Reduced mobility, patient unhappiness, and, in certain situations, the need for additional procedures might be caused by inadequate post-surgery care or delayed rehabilitation.

Germany Hip Replacement Market

Due to a number of circumstances, the German hip replacement market is a significant part of the European orthopedic sector. Due to the nation's substantial aging population, age-related hip conditions including osteoarthritis are becoming more common. The demand for hip replacement surgeries has increased as a result of improvements in patient outcomes and shorter recovery times brought about by advancements in surgical techniques, such as robotic-assisted surgeries and minimally invasive procedures. The availability of high-quality implants and growing healthcare costs are further factors driving the market's expansion. With a rise in the use of primary and revision hip replacement surgeries, Germany is predicted to maintain its position as the market leader in Europe.

France Hip Replacement Market

The market for hip replacements in France is fueled by an aging population, which raises the incidence of hip conditions including osteoarthritis. Improvements in surgical methods, such as robotic-assisted operations and minimally invasive treatments, which increase accuracy and shorten recovery times, are also contributing to the rising demand for joint replacement surgery. Improved access to medical services and rising healthcare costs contribute to the market's expansion. Furthermore, advancements in surgical tools and implant materials lead to improved patient outcomes and a rise in the use of hip replacements, which guarantees the market's sustained growth in the years to come.

United Kingdom Hip Replacement Market

The aging population and rising incidence of hip conditions, especially osteoarthritis, are driving the hip replacement market in the United Kingdom. Surgical technique advancements include robotic-assisted surgeries and minimally invasive treatments are improving patient outcomes, decreasing recuperation times, and increasing surgical precision. Hip replacement procedures are becoming more and more popular as healthcare costs rise and more people look for practical answers to their mobility and hip pain problems. The industry is anticipated to grow as more people choose hip replacements to enhance their quality of life, despite obstacles including NHS waiting lists and growing private healthcare expenses.

Europe Hip Replacement Market Segmentation:

Product

  • Total HIP Replacement
  • Partial HIP Replacement
  • Revision HIP Replacement

End User

  • Hospitals & Surgery Centers
  • Orthopaedic clinics
  • Others

Countries

  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Belgium
  • Netherlands
  • Russia
  • Poland
  • Greece
  • Norway
  • Romania
  • Portugal
  • Rest of Europe

All companies have been covered from 4 viewpoints:

  • Overview
  • Key Persons
  • Recent Development
  • Financial Insights

Company Analysis

1. Smith & Nephew PLC

2. Johnson & Johnson

3. Integra lifesciences Corporation

4. MicroPort Scientific Corp

5. Zimmer Biomet Holdings Inc

6. Stryker Corporation

7. B. Braun Melsungen AG

8. Globus Medical Inc.

Table of Contents

1. Introduction

2. Research & Methodology

  • 2.1 Data Source
    • 2.1.1 Primary Sources
    • 2.1.2 Secondary Sources
  • 2.2 Research Approach
    • 2.2.1 Top-Down Approach
    • 2.2.2 Bottom-Up Approach
  • 2.3 Forecast Projection Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Europe Hip Replacement Market

  • 5.1 Historical Market Trends
  • 5.2 Market Forecast

6. Europe Hip Replacement Market Share Analysis

  • 6.1 By Product
  • 6.2 By End User
  • 6.3 By Countries

7. Product

  • 7.1 Total
  • 7.2 Partial
  • 7.3 Revision & Hip Resurfacing

8. End User

  • 8.1 Hospitals & Surgery Centers
  • 8.2 Orthopedic Clinics
  • 8.3 Others

9. Countries

  • 9.1 France
  • 9.2 Germany
  • 9.3 Italy
  • 9.4 Spain
  • 9.5 United Kingdom
  • 9.6 Belgium
  • 9.7 Netherlands
  • 9.8 Russia
  • 9.9 Poland
  • 9.10 Greece
  • 9.11 Norway
  • 9.12 Romania
  • 9.13 Portugal
  • 9.14 Rest of Europe

10. Porter's Five Forces Analysis

  • 10.1 Bargaining Power of Buyers
  • 10.2 Bargaining Power of Suppliers
  • 10.3 Degree of Rivalry
  • 10.4 Threat of New Entrants
  • 10.5 Threat of Substitutes

11. SWOT Analysis

  • 11.1 Strength
  • 11.2 Weakness
  • 11.3 Opportunity
  • 11.4 Threat

12. Key Players Analysis

  • 12.1 Smith & Nephew PLC
    • 12.1.1 Overviews
    • 12.1.2 Key Person
    • 12.1.3 Recent Developments & Strategies
    • 12.1.4 Revenue Analysis
  • 12.2 Johnson & Johnson
    • 12.2.1 Overviews
    • 12.2.2 Key Person
    • 12.2.3 Recent Developments & Strategies
    • 12.2.4 Revenue Analysis
  • 12.3 Integra lifesciences Corporation
    • 12.3.1 Overviews
    • 12.3.2 Key Person
    • 12.3.3 Recent Developments & Strategies
    • 12.3.4 Revenue Analysis
  • 12.4 MicroPort Scientific Corp
    • 12.4.1 Overviews
    • 12.4.2 Key Person
    • 12.4.3 Recent Developments & Strategies
    • 12.4.4 Revenue Analysis
  • 12.5 Zimmer Biomet Holdings Inc
    • 12.5.1 Overviews
    • 12.5.2 Key Person
    • 12.5.3 Recent Developments & Strategies
    • 12.5.4 Revenue Analysis
  • 12.6 Stryker Corporation
    • 12.6.1 Overviews
    • 12.6.2 Key Person
    • 12.6.3 Recent Developments & Strategies
    • 12.6.4 Revenue Analysis
  • 12.7 B. Braun Melsungen AG
    • 12.7.1 Overviews
    • 12.7.2 Key Person
    • 12.7.3 Recent Developments & Strategies
    • 12.7.4 Revenue Analysis
  • 12.8 Globus Medical Inc
    • 12.8.1 Overviews
    • 12.8.2 Key Person
    • 12.8.3 Recent Developments & Strategies
    • 12.8.4 Revenue Analysis
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!